Inactive Instrument

Other languages OHR Pharmaceutical Inc Nasdaq

Equities

US67778H3093

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading	Mar. 26
US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings	Mar. 26
Top Premarket Decliners	Mar. 26
NeuBase Therapeutics, Inc. Announces CEO Changes	Jan. 17
NeuBase Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Neubase Therapeutics, Inc. Announces Franklyn G. Prendergast Board of Directors Passed Away	23-10-20
Top Premarket Decliners	23-09-07
Top Midday Gainers	23-09-06
NEUBASE THERAPEUTICS SHARES UP 40% AFTER SYMETRYX CORPORATION AC…	23-09-06
Top Premarket Gainers	23-09-06
NeuBase Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
NeuBase Therapeutics to Explore Strategic Alternatives	23-08-03
NeuBase Therapeutics, Inc. Presents Non-Human Primate Data Illustrating Stealth Editors Are Non-Immunogenic, Opening the Door to Redosing	23-06-29
NeuBase Therapeutics Launches $5 Million Registered Direct Offering, Concurrent Private Placement	23-06-28
Neubase Therapeutics, Inc. Announces Positive Preclinical Data Supporting the Capabilities of Stealth Editors	23-05-22
NeuBase Therapeutics, Inc. Announces Resignation of Eric J. Ende as Board of Director	23-05-18
NeuBase Therapeutics, Inc. Announces Formation of Gene Editing Advisory Board	23-05-16
NeuBase Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2023	23-05-11
NeuBase Therapeutics, Inc. Approves Change of Fiscal Year from the Twelve Months Beginning October 1 and Ending September 30 to the Twelve Months Beginning January 1 and Ending December 31	23-04-24
NeuBase Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	23-02-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages OHR Pharmaceutical Inc Nasdaq

Equities

US67778H3093

Other languages

Filters